Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in the western world, and the mortality rate from PCa in Asia has been increasing recently. Statins are potent inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treating hyperlipidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-An, Lin, Ying-Ju, Lin, Cheng-Li, Lin, Hwai-Jeng, Wu, Hua-Shan, Hsu, Hui-Ying, Sun, Yu-Chen, Wu, Hui-Yu, Lai, Chih-Ho, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874326/
https://www.ncbi.nlm.nih.gov/pubmed/29623039
http://dx.doi.org/10.3389/fphar.2018.00225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874326/
https://www.ncbi.nlm.nih.gov/pubmed/29623039
http://dx.doi.org/10.3389/fphar.2018.00225

Ejemplares similares